from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0239/vapB24

LFCtreatmentdescriptionclass of inhibitor

0.870

Amikacinug/mL Amikacintranslation

0.223

Cap5-10ug/mL Capreomycintranslation

-0.043

Rox10-50 ug/mL Roxithromycintranslation

0.807

SM2-5 ug/mL Streptomycintranslation

-0.537

Tet5-10 ug/mL Tetracyclinetranslation

-2.267

Rif0.2-5ug/mL Rifampicintranscription

-1.709

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.308

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.450

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.477

CPZ10-50 ug/mL Chlorpromazinerespiration

0.479

Clofazimine10-13 ug/mL Clofaziminerespiration

0.200

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.823

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.479

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.191

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.095

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.614

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.614

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.326

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.925

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.435

KCN5-20 ug/mL Potassium cyaniderespiration

0.713

NaN30.2-2 mM Sodium aziderespiration

-1.254

Nigericin50 uM Nigericinrespiration

-0.580

TRC10-150 ug/mL Triclosanrespiration

0.157

TRZ10-25 ug/mL Thioridazinerespiration

1.877

Valinomycin0.5-10 uM Valinomycinrespiration

0.245

ZnSO42 mM ZnSO4respiration

2.382

menadione6-10 ug/mL Menadionerespiration

-0.181

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.184

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.316

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.260

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.316

NRP_1Non-replicating persistence stage 1dosRassociated

0.538

Amp0.2mg/mL AmpicillincellWall

-0.068

Cephalexin20-100 ug/mL CephalexincellWall

0.051

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.746

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.262

EMB10-20 ug/mL EthambutolcellWall

0.366

Eta12-40 ug/mL EthionamidecellWall

1.034

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.100

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.127

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.029

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.214

BZA0.12 mg/mL BenzamidearomaticAmides

0.282

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.267

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-1.634

H2O24 mM hydrogen peroxideDNAdamaging

-1.110

Levo10 ug/mL LevofloxacinDNAdamaging

-0.743

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.534

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.727

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.667

UVUV-irradiationDNAdamaging

1.088

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.427

Antimycin12.5-50 ug/mL Antimycin A?

0.431

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.373

PA_110-50 ug/mL Antitubercular compound PA-1?

0.125

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.647

PA8240.2-2 ug/mL PA-824?

-0.136

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.105

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.189

Verapamil50 uM Verapamil?

0.739

mercaptoethanol2 mM 2-Mercaptoethanol?

0.160

methoxatin10-20 ug/mL Methoxatin?